Infection of cells expressing CXCR4 mutants lacking N-glycosylation at the N-terminal extracellular domain is enhanced for R5X4-dualtropic human immunodeficiency virus type-1
<p>Abstract</p> <p>Background</p> <p>Infection with human immunodeficiency virus type-1 (HIV-1) requires binding of the viral envelope gp120 to CD4 and to the CXCR4 coreceptor. Both, gp120 and CXCR4 are subject to N-glycosylation. Here we investigated the influence of t...
Main Authors: | Schreiber Michael, Polzer Svenja, Thordsen Ingo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2002-12-01
|
Series: | BMC Infectious Diseases |
Online Access: | http://www.biomedcentral.com/1471-2334/2/31 |
Similar Items
-
Comparison of Activity and Safety of DSPAα1 and Its N-Glycosylation Mutants
by: Huakang Peng, et al.
Published: (2023-04-01) -
The N-terminus of CXCR4 splice variants determines expression and functional properties.
by: Hee-Kyung Park, et al.
Published: (2023-01-01) -
The Extended N-Terminal Domain Confers Atypical Chemokine Receptor Properties to CXCR3-B
by: Giulia D’Uonnolo, et al.
Published: (2022-06-01) -
N-glycosylation in sugarcane
by: Maia Ivan G., et al.
Published: (2001-01-01) -
An Agonist of the CXCR4 Receptor Strongly Promotes Regeneration of Degenerated Motor Axon Terminals
by: Samuele Negro, et al.
Published: (2019-09-01)